openPR Logo
Press release

Can we still be cured? Can cancer be cured?

01-12-2025 01:33 PM CET | Health & Medicine

Press release from: IMMU

dendritic cell therapy for cancer diagnosis | IMMUMEDIC Limited (© IMMUMEDIC Limited)

dendritic cell therapy for cancer diagnosis | IMMUMEDIC Limited (© IMMUMEDIC Limited)

Dealing with the subject of cancer quickly reveals the complexity of this disease. The question of how to cure tumors and metastases is anything but simple. There are doctors who firmly believe in the golden standard - chemotherapy, radiotherapy or hormone therapy - and propagate these as universal solutions. Alternative therapies, on the other hand, are often stigmatized; when patients bring such approaches into play, the response is often to point to a lack of studies or accusations of "hocus pocus".

But let's pause for a moment and ask ourselves: what are chemotherapy and radiotherapy really? Our body is an impressive marvel of nature. Chemotherapy means that poison is introduced into our body to fight the enemy "cancer". Every doctor's dream is to make the patient healthy again - but does this really happen through the use of poison?

Historically, witches have also mixed tinctures to cure illnesses, which was not always crowned with success. Scientists estimate that there are around 300 different types of cancer, each with its own challenges. This diversity requires individualized approaches to treatment. Most cancers are treated with chemotherapeutic agents, while others are tackled with radiation or hormone therapies.

According to scientific data, the chances of cure are only 25%! Why is that? Cancer results from a degeneration of cells - it is a clustering of cells that begin to separate from healthy cells and take on a life of their own. These cancer cells deprive other cells of nutrients, isolate themselves and the immune system fights desperately against them. In this context, heat shock proteins play a crucial role by helping to reduce stress in the body. However, natural cell death - apoptosis - is often blocked in cancer cells, allowing them to grow unhindered.

Metastases are the result of this uncontrolled cell division; they spread through our bloodstream and settle elsewhere in the body. Whether these metastases become malignant or merely encapsulated often remains uncertain. Scientists argue that nowadays it is no longer the primary tumor that is the cause of death, but the consequences of the metastases. When you consider that you are considered cured after five tumor-free years, while metastases can take up to ten years to become noticeable, the word "cure" becomes problematic.

Our immune system is already under stress to fight the tumor. If we then use additional chemical or radiation therapies, we put even more pressure on the immune system. It now not only has to fight the tumor, but also the foreign substances - be it toxins or radiation. This can lead to a so-called syntax error in the body! The immune system is fighting on several fronts at the same time; some people can cope with this, while others cannot.

In the insurance industry, it looks like this: The healthy pay for the sick. Costs run into the billions every year and continue to rise. Less expensive and more tolerable therapies are often not even considered; alternative therapies are categorically rejected.

One example: the treatment of a glioblastoma can cost health insurance companies up to 250,000 euros per year. Out of 100 diagnoses, only a handful of patients survive in the first year. Despite the use of chemotherapy and other standard therapies, the benefit often remains questionable - it is known, for example, that chemotherapy cannot cross the blood-brain barrier. This means that although the cytostatic drugs work in the body, they do not reach where they are needed - money is therefore often spent in vain.

It is time to rethink and break new ground! Let's take a look at our immune system: What happens when it recognizes a foreign body? Which mechanisms are activated?

From birth, we have many impressive immune cells - including macrophages and dendritic cells - that specialize in identifying enemies in our body. Helper cells coordinate the immune response and T cells and killer cells are crucial for fighting infected or malignant cells. But what do we do? We switch off these important cells and fight them with our therapies.

Multi-organ failure is one of the most common causes of death worldwide and therapeutic approaches such as chemotherapy play a crucial role in this. Paracelsus said: "The dose makes the poison" - every doctor knows that!

Numerous medical experts agree: before we start with aggressive therapies, we should support our immune system and help it to regenerate itself. After that, there is still time for conventional therapies.

Every day we receive new reports about advances in research. Where we once needed decades to develop new treatments, we may now be able to make significant progress in five years or less. The realization remains: Let's work with our immune system instead of against it - that way we significantly increase our chances of a better quality of life and a cure!

Dendritic cell therapy: a beacon of hope in the fight against cancer

Dendritic cell therapy is an innovative immunotherapy that has the potential to make a lasting difference to the lives of cancer patients by activating their own immune system to take targeted action against tumors. This therapy uses dendritic cells that recognize tumor antigens and stimulate the immune response, which leads to a specific fight against cancer cells and minimizes side effects. The use of this therapy is particularly promising for melanoma, breast, prostate and lung cancer, while future developments are aimed at individualizing treatment and combina(on with other therapies.

Conclusion:

Dendritic cell therapy represents a remarkable advance in cancer treatment, as confirmed by over 200,000 studies, which not only has the potential to improve patients' quality of life, but also fundamentally changes the way we think about fighting tumors. This innovative therapy harnesses the extraordinary abilities of dendritic cells, which are key players in our immune system, to target cancer cells. By recognizing tumor antigens and activating the immune system, dendritic cells provide a tailored response to the specific challenges posed by different types of cancer. The successes to date in clinical trials and patient testimonials impressively demonstrate that this form of therapy not only brings hope to many patients, but also heralds a new era in cancer immunotherapy. Nevertheless, we must not ignore the challenges and limitations. The variability in treatment outcomes and the technological hurdles require continuous research and development to maximize the efficacy and accessibility of this therapy. At the same time, the possibility of combining it with other immunological approaches opens up new perspectives for future treatments. It is important that patients and relatives are well informed and have access to the latest developments in dendritic cell therapy. We therefore invite you to find out more about this promising form of therapy and learn more about its possible applications. Visit our website under "Dendritic Cell Therapy Germany" to obtain valuable information and keep up to date with the latest studies and developments. In summary, dendritic cell therapy not only represents a significant advance in the treatment of cancer, but is also a ray of hope for many patients who are looking for effective and gentle treatment options. The combination of scientific progress and the tireless efforts of researchers and clinics gives us every reason to hope for a better future in the fight against cancer.

"ONLY OUR OWN IMMUNE SYSTEM IS CAPABLE OF FREEING US FROM CANCER!"

IMMUMEDIC Limited
130 Leinster Road
D06AW84 Dublin 6
Irland

https://www.dendritische-zelltherapie-deutschland.com/impressum

Herr Andreas Rach
+49 160 9194 2558

immumedic@gmail.com

IMMUMEDIC Limited - Your partner for medical logistics and immunotherapy
Dear medical professionals and patients

We at IMMUMEDIC Limited are proud to be at your side as an international medical service provider. With our many years of expertise and as a cooperation partner with GMP-certified laboratories based in Europe, we are the leading partner for your needs in immunotherapy for cancer diagnosis and autoimmune diseases.

Our aim is to work with you to find the best solutions for your patients. That is why we offer you the therapeutic options of special cells (DCs), including autologous vaccines for immunological cancer therapy and defect drugs to combat metastases and apoptosis in the cancer cell. These high-quality therapies are produced individually from the blood of your customers/patients to enable customized treatment.

But our vision goes beyond therapy options - we want to ensure that you and your patients have access to our innovative therapy options at all times. That's why we have developed a revolutionary medical transportation logistics system that represents a milestone in our business policy. With the help of these logistics, we can deliver or facilitate the necessary blood collection kits and therapies quickly and efficiently.

We understand the value of time in medical practice. That's why we guarantee punctual processing and a smooth workflow so that you can concentrate fully on treating your patients. Our logistics experts work closely with you to find customized solutions for your individual requirements.

At IMMUMEDIC Limited, we put people first. We are passionate about ensuring that your patients receive the best possible care and that their quality of life is improved. With our innovative medical technology and highly skilled team, we want to help ensure that cancer diagnoses and autoimmune diseases are no longer seen as insurmountable hurdles.

Together we can achieve great things - let's unite in the fight against these diseases and give your patients new treatment options.
Contact us today and discover the benefits of partnering with IMMUMEDIC Limited!

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Can we still be cured? Can cancer be cured? here

News-ID: 3811290 • Views:

More Releases from IMMU

Treatment of metastases
05-31-2025 | Health & Medicine
IMMU
Treatment of metastases
As an affected patient, you are aware of one thing: when you are diagnosed with cancer, everything changes, from your quality of life to your everyday life. Surgical removal of the primary tumor is often attempted. If this does not work, radiotherapy or chemotherapy is tried, and hormone therapy is also used for certain types of cancer. Most doctors who do not work scientifically are skeptical of the new forms
**The cancer clock is ticking - A ray of hope in the fight against tumors and metastases**
04-02-2025 | Health & Medicine
IMMU
**The cancer clock is ticking - A ray of hope in the fight against tumors and me …
Every year, over 600,000 people in Germany are diagnosed with cancer. Statistically, most people die from pancreatic cancer, lung cancer, breast cancer, bowel cancer, prostate cancer, glioblastoma, etc. Common therapeutic measures such as surgery, radiotherapy and chemotherapy are the gold standard in treatment. However, immunotherapy is becoming increasingly important to counteract these diverse challenges. However, it is important to know that not every immunotherapy is equally valuable. Some forms of
The key to fighting cancer: Dendritic cell therapy ?
03-23-2025 | Health & Medicine
IMMU
The key to fighting cancer: Dendritic cell therapy ?
In today's world, where we are constantly faced with new challenges in the field of cancer treatment, it is crucial to pursue innovative approaches. One promising method is therapy with tumor antigen-loaded dendritic cells. A functioning immune system plays a central role in fighting tumors and metastases. But how can we specifically support the immune system? Autologous dendritic cell therapy, produced from the blood of the affected patient, offers a promising
Harness the power of your immune system with dendritic cells
02-17-2025 | Health & Medicine
IMMU
Harness the power of your immune system with dendritic cells
In modern medicine, the understanding of the immune system and its role in the fight against cancer is becoming increasingly important. Dendritic cells, a key component of our immune system immune system, play a crucial role in this. These specialized immune cells are responsible for responsible for recognizing foreign structures such as tumour cells and activating the immune system. But what does this mean for patients suffering from cancer? And how can dendritic cells

All 5 Releases


More Releases for IMMUMEDIC

05-31-2025 | Health & Medicine
IMMU
Treatment of metastases
As an affected patient, you are aware of one thing: when you are diagnosed with cancer, everything changes, from your quality of life to your everyday life. Surgical removal of the primary tumor is often attempted. If this does not work, radiotherapy or chemotherapy is tried, and hormone therapy is also used for certain types of cancer. Most doctors who do not work scientifically are skeptical of the new forms
04-02-2025 | Health & Medicine
IMMU
**The cancer clock is ticking - A ray of hope in the fight against tumors and me …
Every year, over 600,000 people in Germany are diagnosed with cancer. Statistically, most people die from pancreatic cancer, lung cancer, breast cancer, bowel cancer, prostate cancer, glioblastoma, etc. Common therapeutic measures such as surgery, radiotherapy and chemotherapy are the gold standard in treatment. However, immunotherapy is becoming increasingly important to counteract these diverse challenges. However, it is important to know that not every immunotherapy is equally valuable. Some forms of
02-17-2025 | Health & Medicine
IMMU
Harness the power of your immune system with dendritic cells
In modern medicine, the understanding of the immune system and its role in the fight against cancer is becoming increasingly important. Dendritic cells, a key component of our immune system immune system, play a crucial role in this. These specialized immune cells are responsible for responsible for recognizing foreign structures such as tumour cells and activating the immune system. But what does this mean for patients suffering from cancer? And how can dendritic cells